An exploration of the pivotal BHAT and ISIS-I trials. Both of which significantly impacted physicians' use of beta-blockers in patients with acute myocardial infarction. However, there is still more to uncover! Get full access to Cardiology Trial’s Substack at cardiologytrials.substack.com/subscribe